| Pubmed ID |
Author |
Year |
Title |
|
28042411
|
Kahyaoglu S
|
2017
|
Clomiphene Citrate Treatment Cycle Outcomes of Polycystic Ovary Syndrome Patients Based on Basal High Sensitive C-Reactive Protein Levels: A Cross-Sectional Study.
|
|
28042549
|
Foroozanfard F
|
2017
|
Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome.
|
|
28043072
|
Guo Z
|
2017
|
Association of serum organochlorine pesticides concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population.
|
|
28045919
|
Lindheim L
|
2017
|
Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
|
|
28049245
|
Shin JJ
|
2017
|
Major Disease Prevalence and Menstrual Characteristics in Infertile Female Korean Smokers.
|
|
28051267
|
Tan J
|
2016
|
Reduced expression of SCF in serum and follicle from patients with polycystic ovary syndrome.
|
|
28051885
|
Deng H
|
2017
|
Elevated serum interferon ?-inducible protein-10 in women with polycystic ovary syndrome.
|
|
28051891
|
Yin D
|
2017
|
The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.
|
|
28058854
|
Patel R
|
2017
|
Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
|
|
28060790
|
Sun X
|
2017
|
Family-Based Association Study of rs17300539 and rs12495941 Polymorphism in Adiponectin Gene and Polycystic Ovary Syndrome in a Chinese Population.
|
|
28068351
|
Pau CT
|
2017
|
Phenotype and Tissue Expression as a Function of Genetic Risk in Polycystic Ovary Syndrome.
|
|
28069449
|
Graham EJ
|
2017
|
A model of ovulatory regulation examining the effects of insulin-mediated testosterone production on ovulatory function.
|
|
28069897
|
Armeni AK
|
2017
|
Impact of estrogen receptor ? gene and oxytocin receptor gene polymorphisms on female sexuality.
|
|
28070371
|
Williams S
|
2015
|
'Everything's from the inside out with PCOS': Exploring women's experiences of living with polycystic ovary syndrome and co-morbidities through Skype? interviews.
|
|
28070801
|
Noroozzadeh M
|
2017
|
A Comparison of Sexual Function in Women with Polycystic Ovary Syndrome (PCOS) Whose Mothers Had PCOS During Their Pregnancy Period with Those Without PCOS.
|
|
28071011
|
Swora-Cwynar E
|
2016
|
The effects of a low-calorie diet or an isocaloric diet combined with metformin on sex hormones In obese women of child-bearing age.
|
|
28079802
|
Jiang LL
|
2017
|
Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome.
|
|
28081274
|
Wu JB
|
2016
|
Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk.
|
|
28081337
|
Akda? Cirik D
|
2016
|
Do anxiety and depression statuses differ in differentpolycystic ovary syndrome phenotypes?
|
|
28082237
|
Niu Z
|
2017
|
Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization.
|
|
28082338
|
McLuskie I
|
2017
|
New diagnosis of polycystic ovary syndrome.
|
|
28082426
|
Selen Alpergin ES
|
2017
|
Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine.
|
|
28083040
|
Chen Z
|
2016
|
Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome.
|
|
28088464
|
Carvalho LM
|
2017
|
Microparticles: Inflammatory and haemostatic biomarkers in Polycystic Ovary Syndrome.
|
|
28088992
|
Ranasinghe GC
|
2017
|
Prevalence of hormonal and endocrine dysfunction in patients with lichen planopilaris (LPP): A retrospective data analysis of 168 patients.
|
|
28089571
|
Pinola P
|
2017
|
Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
|
|
28090348
|
Stener-Victorin E
|
2016
|
Changes in HbA<sub>1c</sub> and circulating and adipose tissue androgen levels in overweight-obese women with polycystic ovary syndrome in response to electroacupuncture.
|
|
28090459
|
Hestiantoro A
|
2016
|
Anti-M?llerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate.
|
|
28091905
|
Kolesnikova LI
|
2017
|
Activity of LPO Processes in Women with Polycystic Ovarian Syndrome and Infertility.
|
|
28092404
|
Tagliaferri V
|
2017
|
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study.
|
|
28093231
|
Pournaderi PS
|
2017
|
The effects of 6-Gingerol on reproductive improvement, liver functioning and Cyclooxygenase-2 gene expression in estradiol valerate - Induced polycystic ovary syndrome in Wistar rats.
|
|
28096785
|
Mansour A
|
2016
|
Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome.
|
|
28099123
|
Alexiou E
|
2017
|
Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index.
|
|
28099715
|
Macruz CF
|
2017
|
Assessment of the body composition of patients with polycystic ovary syndrome using dual-energy X-ray absorptiometry.
|
|
28102491
|
Muscogiuri G
|
2017
|
Shedding new light on female fertility: The role of vitamin D.
|
|
28104244
|
Lee I
|
2017
|
Increased risk of disordered eating in?polycystic ovary syndrome.
|
|
28104402
|
Engmann L
|
2017
|
Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype.
|
|
28107851
|
Fang F
|
2017
|
Effect of vitamin D supplementation on polycystic ovary syndrome: A?systematic review and meta-analysis of randomized controlled trials.
|
|
28108363
|
Mudrovcic N
|
2017
|
Endothelial maintenance in health and disease: Importance of sex differences.
|
|
28109841
|
Patel S
|
2017
|
Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review.
|
|
28116888
|
Jin SG
|
2017
|
The fertilization potential of oocytes may be compromised in women with polycystic ovary syndrome.
|
|
28118681
|
Bordewijk EM
|
2017
|
Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome.
|
|
28119323
|
Nylander M
|
2017
|
Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential.
|
|
28119448
|
Wang R
|
2017
|
The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?
|
|
28122439
|
Liu AL
|
2016
|
New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian Cancer
|
|
28123936
|
Stechemesser L
|
2017
|
Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
|
|
28125989
|
Liao Y
|
2017
|
An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
|
|
28127831
|
Reis GV
|
2017
|
Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review.
|
|
28128085
|
Przepiera-B?dzak H
|
2016
|
Antiphospholipid Syndrome with Anti?2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
|
|
28132572
|
Cui N
|
2017
|
Decreased expression of fatty acid amide hydrolase in women with polycystic ovary syndrome.
|
|
28135285
|
Ujvari D
|
2017
|
Dysregulation of In Vitro Decidualization of Human Endometrial Stromal Cells by Insulin via Transcriptional Inhibition of Forkhead Box Protein O1.
|
|
28139236
|
Roesner S
|
2017
|
Time-lapse imaging reveals differences in growth dynamics of embryos after in?vitro maturation compared with conventional stimulation.
|
|
28139507
|
Tan J
|
2017
|
Increased Risk of Psychiatric Disorders in Women with Polycystic Ovary Syndrome in Southwest China.
|
|
28139522
|
Zhou F
|
2017
|
Ovarian Fibrosis: A Phenomenon of Concern.
|
|
28139539
|
Reddy BM
|
2016
|
Association of type 2 diabetes mellitus genes in polycystic ovary syndrome aetiology among women from southern India.
|
|
28139558
|
Durmanova AK
|
2016
|
[Anti-M?llerian hormone as an indicator of reproductive health in women with obesity and concomitant polycystic ovary syndrome].
|
|
28141959
|
Celik F
|
2017
|
Plasma L-carnitine levels of obese and non-obese polycystic ovary syndrome patients.
|
|
28142296
|
Ahmadi S
|
2017
|
Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
|
|
28143456
|
Jensterle M
|
2017
|
Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial.
|
|
28143834
|
Wang R
|
2017
|
Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis.
|
|
28145863
|
Gu HF
|
2016
|
The association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome.
|
|
28146139
|
Papadakis G
|
2017
|
Is cardiovascular risk in women with PCOS a real risk? Current insights.
|
|
28149157
|
Yonggang H
|
2017
|
Effects of human chorionic gonadotropin combined with clomiphene on Serum E<sub>2</sub>, FSH, LH and PRL levels in patients with polycystic ovarian syndrome.
|
|
28152641
|
Kulkarni M
|
2017
|
A review of paediatric and adolescent gynaecology services in a tertiary outpatient clinic.
|
|
28156151
|
Jellinger PS
|
2017
|
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY<sub>Complete Appendix to Guidelines available at http://journals.aace.com</sub>.
|
|
28157253
|
Ambroziak U
|
2017
|
Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
|
|
28157691
|
Figurov? J
|
2017
|
The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome.
|
|
28159846
|
Lai L
|
2017
|
Standardised versus individualised multiherb Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: a randomised feasibility and pilot study in the UK.
|
|
28160242
|
Mazloomi S
|
2017
|
Serum Zinc and Adiponectin Levels in Patients with Polycystic Ovary Syndrome, Adjusted for Anthropometric, Biochemical, Dietary Intake, and Physical Activity Measures.
|
|
28165551
|
Kowalczyk K
|
2017
|
Thyroid disorders in polycystic ovary syndrome.
|
|
28168653
|
Freis A
|
2017
|
Effects of a hyperandrogenaemic state on the proliferation and decidualization potential in human endometrial stromal cells.
|
|
28168992
|
?zdemir O
|
2016
|
The relationship between atypical depression and ins?lin resistance in patients with polycystic ovary syndrome and major depression.
|
|
28175322
|
Poromaa IS
|
2017
|
Should we individualize lipid profiling in women with polycystic ovary syndrome?
|
|
28176325
|
Shafiee MN
|
2017
|
Sterol regulatory element binding protein-1 (SREBP1) gene expression is similarly increased in polycystic ovary syndrome and endometrial cancer.
|
|
28177124
|
Dantas WS
|
2017
|
Acute exercise elicits differential expression of insulin resistance genes in the skeletal muscle of patients with polycystic ovary syndrome.
|
|
28178574
|
Uysal G
|
2017
|
Is acne a sign of androgen excess disorder or not?
|
|
28182154
|
Karaca Ad?yeke S
|
2017
|
Anterior Segment Findings in Women with Polycystic Ovary Syndrome.
|
|
28182362
|
Li N
|
2017
|
Upregulation of FoxO 1 Signaling Mediates the Proinflammatory Cytokine Upregulation in the Macrophage from Polycystic Ovary Syndrome Patients.
|
|
28183310
|
Paix?o L
|
2017
|
Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.
|
|
28187771
|
Homer MV
|
2017
|
The effect of estradiol on granulosa cell responses to FSH in women with polycystic ovary syndrome.
|
|
28190890
|
Stassek J
|
2017
|
C-Peptide, Baseline and Postprandial Insulin Resistance after a Carbohydrate-Rich Test Meal - Evidence for an Increased Insulin Clearance in PCOS Patients?
|
|
28193283
|
Xiong W
|
2017
|
Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population.
|
|
28195137
|
Peng Y
|
2017
|
ERBB4 Confers Risk for Polycystic Ovary Syndrome in Han Chinese.
|
|
28199736
|
Dokras A
|
2017
|
Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome.
|
|
28201826
|
Mario FM
|
2017
|
Adiposity Indexes as Phenotype-Specific Markers of Preclinical Metabolic Alterations and Cardiovascular Risk in Polycystic Ovary Syndrome: A Cross-Sectional Study.
|
|
28203719
|
Roberts JS
|
2017
|
High-fat high-sugar diet induces polycystic ovary syndrome in a rodent model?.
|
|
28208942
|
Shayan A
|
2016
|
Comparing the Effects of Agnugol and Metformin on Oligomenorrhea in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial.
|
|
28211992
|
Speer AL
|
2017
|
Thirty-day outcomes for children and adolescents undergoing laparoscopic sleeve gastrectomy at a free-standing children's hospital.
|
|
28212475
|
Carranza-Lira S
|
2017
|
[Frequency of increased thyrotropin in women with hyperprolactinemia].
|
|
28216918
|
Verma S
|
2016
|
Spontaneous conception in 40-year-old infertile woman with polycystic ovaries after complete reversal of endometrial intraepithelial neoplasia: A case report with review of literature.
|
|
28222635
|
Qu Q
|
2017
|
Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome.
|
|
28222828
|
Jeanes YM
|
2017
|
Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
|
|
28224431
|
Zhang F
|
2017
|
Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
|
|
28228317
|
Elkind-Hirsch KE
|
2017
|
Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
|
|
28228318
|
Daan NM
|
2017
|
Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome.
|
|
28234803
|
Turcu AF
|
2017
|
Clinical significance of 11-oxygenated androgens.
|
|
28235206
|
Nasri K
|
2017
|
The Effects of Omega-3 Fatty Acids Supplementation on Gene Expression Involved in the Insulin and Lipid Signaling Pathway in Patients with Polycystic Ovary Syndrome.
|
|
28235465
|
Tal R
|
2017
|
Ovarian reserve testing: a user's guide.
|
|
28238455
|
Metzler VM
|
2017
|
Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development.
|
|
28238496
|
Liang P
|
2017
|
Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome.
|